Cancer after exposure to radiation in the course of treatment for benign and malignant disease

The Lancet Oncology
M P Little

Abstract

This review assesses the patterns of radiation-associated relative risks of cancer incidence and mortality in groups exposed to ionising radiation in the course of treatment for various malignant and non-malignant conditions. In general, the relative risks among Japanese survivors of atomic-bomb explosions are greater than those among comparable subsets in studies of medically exposed individuals. Cell sterilisation largely accounts for the discrepancy in the relative risks between these two populations, although other factors may contribute, such as the generally higher underlying cancer risks in the medical series than in the Japanese atomic-bomb survivors, and dose-fractionation effects. The higher underlying cancer risk in some of the medically exposed populations, in particular for those with cancer-prone conditions, implies that the absolute excess risk is sometimes higher than in the Japanese data. For these cancer-prone individuals, the increase in absolute risk for those receiving the large doses of radiation associated with radiotherapy may be quite significant. This increase in risk has to be balanced against the generally high spontaneous cancer risk in these individuals and the benefits accruing from radiotherapy.

References

Jul 14, 1992·Lancet·P HallJ Tennvall
Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·J M KaldorV Blair
Sep 2, 1992·Journal of the National Cancer Institute·M Andersson, H H Storm
Jul 5, 1992·The New England Journal of Medicine·R E CurtisR N Hoover
Sep 1, 1989·Medical Physics·M StovallM Rosenstein
Aug 17, 1988·Journal of the National Cancer Institute·S Preston-MartinD Cohen
Sep 3, 1987·The New England Journal of Medicine·M A TuckerW Newton
Oct 18, 1995·Journal of the National Cancer Institute·F E van LeeuwenR Somers
Nov 1, 1994·International Journal of Cancer. Journal International Du Cancer·H A WeissR Doll
Jul 6, 1994·Journal of the National Cancer Institute·P D InskipJ T Flannery
Mar 15, 1994·International Journal of Cancer. Journal International Du Cancer·S C DarbyM Stovall
Mar 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·I DialloJ Chavaudra
Apr 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R EpsteinR Dale
Jun 4, 1998·Clinical Oncology : a Journal of the Royal College of Radiologists·B W Fox
Oct 10, 1998·International Journal of Cancer. Journal International Du Cancer·M P LittleC R Muirhead
Sep 3, 1999·Occupational and Environmental Medicine·K RadonD Szadkowski
Dec 11, 1999·Cancer Investigation·M R SpitzX Wu
Jun 30, 2001·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·UNKNOWN International Commission on Radiological Protection.
Jan 1, 1996·International Journal of Radiation Oncology, Biology, Physics·P J Deschavanne, B Fertil

❮ Previous
Next ❯

Citations

May 20, 2011·Nature Reviews. Cancer·Wayne D Newhauser, Marco Durante
Jul 11, 2003·Health Physics·Elaine Ron
May 26, 2012·Surgical Neurology International·Abhineet ChowdharyDaniel L Silbergeld
Sep 10, 2005·Proceedings of the National Academy of Sciences of the United States of America·Rainer K Sachs, David J Brenner
Sep 15, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Erlend RennemoMorten Boysen
Nov 26, 2009·American Journal of Industrial Medicine·Sylvie GuérinFlorent de Vathaire
Mar 16, 2005·Cancer Letters·Mia HashibeZuo-Feng Zhang
Jul 26, 2005·European Journal of Radiology·Alev KadiogluOmer Uysal
May 8, 2014·International Journal of Radiation Oncology, Biology, Physics·Arshin SheybaniGeraldine M Jacobson
May 25, 2015·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Giancarlo TirelliMarco Piovesana
Aug 29, 2007·Radiation Research·D L PrestonK Kodama
Dec 19, 2014·General Thoracic and Cardiovascular Surgery·Shigeki SawadaMotohiro Yamashita
Dec 24, 2002·The Journal of Pharmacy and Pharmacology·Tat Khuen Lee, Ieva Stupans
Jul 9, 2008·Acta Oncologica·Luca IncrocciHeinrich M Seegenschmiedt
Feb 6, 2004·British Medical Bulletin·M P Little
Jan 9, 2013·Journal of Radiological Protection : Official Journal of the Society for Radiological Protection·Richard Wakeford
Oct 19, 2006·Mutation Research·Vipan Kumar PariharC Mallikarjuna Rao
Jan 9, 2007·European Journal of Pharmacology·Vipan Kumar PariharChamallamudi Mallikajuna Rao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.